127 results
Page 4 of 7
6-K
EX-99.1
9kofceo5f4ak 7nzkoke
3 Mar 15
Current report (foreign)
12:00am
F-3/A
km9jvfatah1
24 Dec 14
Shelf registration (foreign) (amended)
12:00am
6-K
q4w lve58
9 Dec 14
Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting
12:00am
6-K
EX-99.1
c2jbhhu 7b
9 Dec 14
Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting
12:00am
6-K
EX-99.1
7v2wlux9
3 Dec 14
Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meeting
12:00am
6-K
knjvdgflr8dd7z5 f5mr
3 Dec 14
Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meeting
12:00am
6-K
EX-99.1
9eixfzsbscd5t
29 Sep 14
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University
12:00am
6-K
EX-99.3
972ahpd78w
17 Jul 14
Consolidated Financial Statements of
12:00am
6-K
EX-99.2
z4dggr0 k85y6yi3qs0
17 Jul 14
Consolidated Financial Statements of
12:00am
6-K
EX-99.2
cne28k
22 Apr 14
Condensed Consolidated Interim Statements of Financial Position
12:00am
6-K
EX-99.3
2afo3oj5cftdwzp pr
11 Feb 14
Lorus Therapeutics Reports Second Quarter Results for Fiscal 2014
12:00am
6-K
EX-99.9
0gmrogj
6 Feb 14
Lorus Therapeutics to Present at Biotech ShowcaseTM 2014
12:00am
6-K
EX-99.10
prx4zojxsksn3xolx6
6 Feb 14
Lorus Therapeutics to Present at Biotech ShowcaseTM 2014
12:00am